AcelRx Pharmaceuticals

$2.20
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.05 (-2.22%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell ACRX and other stocks, options, ETFs, and crypto commission-free!

About ACRX

AcelRx Pharmaceuticals, Inc. engages in the development and commercialization of therapies use in medically supervised settings. Its products include sufentanil, DZUVEO, DSUVIA ZALVISO US and ZALVISO EU. Read More The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in Redwood City, CA.

Employees
61
Headquarters
Redwood City, California
Founded
2005
Market Cap
174.76M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
754.55K
High Today
$2.27
Low Today
$2.16
Open Price
$2.22
Volume
833.65K
52 Week High
$5.05
52 Week Low
$1.99

Collections

ACRX News

ReutersAug 12

Edited Transcript of ACRX earnings conference call or presentation 5-Aug-19 9:00pm GMT

81

ACRX Earnings

-$0.24
-$0.21
-$0.19
-$0.16
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 1, After Hours

Popular Stocks

More ACRX News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.